Takeda Pharmaceutical Company Limited has recently announced the addition of five partners to its Global CSR Program for 2019, which contributes to the long-term health of people through disease prevention and capacity building in developing and emerging countries.

 

Approximately 20,000 employees worldwide cast their votes, selecting five new, large-scale programs run, respectively, by City Cancer Challenge, Drugs for Neglected Diseasesinitiative(DNDi), SeriousFun Children’s Network, UNICEF, and the UN Foundation. All five programs are being launched by the aforementioned organizations in partnership with Takeda. This year, Takeda has increased its commitment to 4.6 billion yen to accelerate change for tackling some of the biggest global challenges.

 

It is known that Takeda's Global CSR Programmakes multi-year commitments in partnership with key global stakeholders. The Program is rooted in the company’s patient-centricity and dedication to disease prevention and the improvement of access to healthcare that transforms people's lives in developing and emerging countries. Since its launch in 2016, Global CSR Program partnerships have been delivering tangible results, contributing significantly to global efforts to achieve the Sustainable Development Goals (SDGs). Results range from expanding patient’s access to quality diagnosis and treatment, including immunization, in disease-endemic countries to training health workers and strengthening health systems worldwide.

 

In addition to 14 CSR programs, Takeda also supports public-private partnerships that aim to improve health worldwide, together with the Government of Japan, such as The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Heath Innovative Technology (GHIT) Fund, and Coalition for Epidemic Preparedness Innovations (CEPI).

Takeda's Global CSR Programmakes multi-year commitments in partnership with key global stakeholders. The Program is rooted in the company’s patient-centricity and dedication to disease prevention.